These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20682989)

  • 1. SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells.
    Pohl M; Radacz Y; Pawlik N; Schoeneck A; Baldus SE; Munding J; Schmiegel W; Schwarte-Waldhoff I; Reinacher-Schick A
    Anticancer Res; 2010 Jul; 30(7):2603-13. PubMed ID: 20682989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells.
    Müller N; Reinacher-Schick A; Baldus S; van Hengel J; Berx G; Baar A; van Roy F; Schmiegel W; Schwarte-Waldhoff I
    Oncogene; 2002 Sep; 21(39):6049-58. PubMed ID: 12203117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basement membrane component laminin-5 is a target of the tumor suppressor Smad4.
    Zapatka M; Zboralski D; Radacz Y; Böckmann M; Arnold C; Schöneck A; Hoppe S; Tannapfel A; Schmiegel W; Simon-Assmann P; Schwarte-Waldhoff I
    Oncogene; 2007 Mar; 26(10):1417-27. PubMed ID: 16953227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
    Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
    Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad4-independent TGF-beta signaling in tumor cell migration.
    Giehl K; Imamichi Y; Menke A
    Cells Tissues Organs; 2007; 185(1-3):123-30. PubMed ID: 17587818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.
    Duda DG; Sunamura M; Lefter LP; Furukawa T; Yokoyama T; Yatsuoka T; Abe T; Inoue H; Motoi F; Egawa S; Matsuno S; Horii A
    Oncogene; 2003 Oct; 22(44):6857-64. PubMed ID: 14534532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
    Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells.
    Tian X; Du H; Fu X; Li K; Li A; Zhang Y
    Biochem Biophys Res Commun; 2009 Mar; 380(3):478-83. PubMed ID: 19284991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
    Lee HS; Kim C; Kim SB; Kim MG; Park D
    Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
    Räsänen K; Vaheri A
    J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Smad proteins in the regulation of NF-kappaB by TGF-beta in colon cancer cells.
    Grau AM; Datta PK; Zi J; Halder SK; Beauchamp RD
    Cell Signal; 2006 Jul; 18(7):1041-50. PubMed ID: 16288847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression.
    Schwarte-Waldhoff I; Klein S; Blass-Kampmann S; Hintelmann A; Eilert C; Dreschers S; Kalthoff H; Hahn SA; Schmiegel W
    Oncogene; 1999 May; 18(20):3152-8. PubMed ID: 10340387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of Smad4 regulated transforming growth factor-beta signalling in colon cancer cells.
    Ali NA; McKay MJ; Molloy MP
    Mol Biosyst; 2010 Nov; 6(11):2332-8. PubMed ID: 20862427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RING finger protein11 binds to Smad4 and enhances Smad4-dependant TGF-beta signalling.
    Azmi PB; Seth AK
    Anticancer Res; 2009 Jun; 29(6):2253-63. PubMed ID: 19528490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.